Systematic evaluation of acupuncture therapy intervention with lipid abnormalities and summary evaluation of meta analysis

Objective: Conduct a summary evaluation of current acupuncture therapy for blood lipid abnormalities and meta analysis. Methods By retrieving Pubmed, Embase, Cochrane Library, CBM, CNKI and Omnibus databases, finding the systematic evaluation of acupuncture therapy for blood lipid abnormalities with Meta analysis, using the systematic evaluation methodological quality assessment tool AMSTAR, and using the evidence quality grading tool GRADE system Evaluate the level of evidence. The results were eventually included in a compliant systematic evaluation, comparing acupuncture therapy to drug therapy. The AMSTAR evaluation tool has 11 entries, which show that, on the one side of the entry, the system evaluation does not provide registration information or a study plan; entry 2, which describes two evaluators separately, does not detail information on specific evaluators; in terms of entries 10 and eleven, In the production process, there was no evaluation of bias and no interest in the relevant Conflict description; the remaining seven entries, the system evaluation were more fully explained and illustrated. Grades evidence quality assessment reduces evidence quality due to 5 aspects of “bias risk”, “inconsistency”, “indirection”, “accuracy” and “published bias”. The 10 endgame indicators of concern for the system were assessed, with the quality of evidence at “very low level”, all downgraded due to “bias risk”, “inconsistency” and “published bias”. Conclusion The current systematic evaluation of acupuncture therapy for blood lipid abnormalities is low, methodological quality and low level of evidence, and care should be taken in clinical practice.